This application is for a competing continuation of a P30 Core Center, the Center for Drug Use and HIV Research (CDUHR). A continuation is proposed because (a) advancement in HIV research has led to an increasing focus on social-level influences to help understand HIV risk behaviors and transmission, and (b) the projects that comprise CDUHR provide a unique set of studies through which a range of social-level influences on HIV can be examined and integrated in a multidisciplinary environment. In addition, the need for a Core Center has increased: whereas the parent grant was initiated to provide support to 9 projects related to HIV and drug use, this continuation will provide a research infrastructure for 23 projects. The overarching scientific aim will be to enhance knowledge regarding social-level influences on HIV-related risk behaviors, prevention and transmission of HIV among drug users. CDUHR will provide support to increase the productivity of investigators, foster efficiency in project functioning, and enhance collaboration and synergy so that new research questions and studies will emerge which will exceed the accomplishments achievable by the simple summation of the activities of the individual projects. In addition, CDUHR will support the development of new knowledge, theory and methods and their dissemination to the field.
The aims of CDUHR will be accomplished through 6 cores: (1) Social Theory Core -- furthers the use and development of supra-individual theory; (2) Research Methods Core -- enhances use of newly-emerging social-level research methods; (3) Statistics and Data Analysis Core fosters use of statistical methods that are appropriate for group and multi-level analyses; (4) Strategic Comparisons Core -- facilitates and undertakes studies with epidemics as the unit of analysis; (5) Dissemination and Training Core -- serves to maintain and advance knowledge and skills of staff and disseminate findings to service providers; and (6) Administration Core -- provides scientific leadership and ensures integration across Cores and synergy across projects and investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA011041-06
Application #
6554551
Study Section
Special Emphasis Panel (ZDA1-RXL-E (01))
Program Officer
Lambert, Elizabeth
Project Start
1998-04-01
Project End
2008-03-31
Budget Start
2003-04-15
Budget End
2004-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$892,721
Indirect Cost
Name
National Development & Research Institutes
Department
Type
DUNS #
080481880
City
New York
State
NY
Country
United States
Zip Code
10010
Tempalski, Barbara; Cleland, Charles M; Williams, Leslie D et al. (2018) Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007. Subst Abuse Treat Prev Policy 13:28
Behrends, Czarina N; Nugent, Ann V; Des Jarlais, Don C et al. (2018) Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. J Acquir Immune Defic Syndr 79:e76-e78
Duncan, Dustin T; Chaix, Basile; Regan, Seann D et al. (2018) Collecting Mobility Data with GPS Methods to Understand the HIV Environmental Riskscape Among Young Black Men Who Have Sex with Men: A Multi-city Feasibility Study in the Deep South. AIDS Behav 22:3057-3070
Perlman, David C; Jordan, Ashly E (2018) The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Curr HIV/AIDS Rep 15:96-112
Vasylyeva, Tetyana I; Liulchuk, Mariia; Friedman, Samuel R et al. (2018) Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proc Natl Acad Sci U S A 115:1051-1056
Wolfson-Stofko, Brett; Elliott, Luther; Bennett, Alex S et al. (2018) Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Int J Drug Policy 62:67-73
Palamar, Joseph J (2018) What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA. J Psychoactive Drugs 50:88-93
Wolfson-Stofko, Brett; Gwadz, Marya V; Elliott, Luther et al. (2018) ""Feeling confident and equipped"": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City. Drug Alcohol Depend 192:362-370
Palamar, Joseph J; Acosta, Patricia; Cleland, Charles M (2018) Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees. Subst Use Misuse 53:381-390
Williams, Leslie D; Kostaki, Evangelia-Georgia; Pavlitina, Eirini et al. (2018) Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece. Front Microbiol 9:1825

Showing the most recent 10 out of 339 publications